Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER versus quetiapine and placebo for acute manic or mixed episodes in bipolar I disorder
2005-005812-25Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Paliperidone ER, Quetiapine and Placebo (3 arms). Primary endpoint: Change from baseline in total YMRS score at end of double-blind acute treatment phase. Started Feb 2006; status: completed.
02
Drugs
paliperidonequetiapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2005-005812-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005812-25.